After enduring multiple rounds of layoffs last year, Genentech’s employees are facing more uncertainty as the Roche unit lets ...

NEW YORK (CBS.MW) -- Genentech has perhaps the most storied past of all biotechnology firms, but it's the future that investors want to hear about. The No. 2 biotechnology firm will hold its first ...

How Genentech and other drug makers are stepping ... their way along the fashion show runway ahead of last month’s New York Fashion Week, they made a statement. They also broke new ground ...

NEW YORK (AP) — Genentech on Monday urged shareholders to reject a $42 billion hostile buyout bid from Swiss drugmaker Roche. A Genentech committee said the offer is inadequate and not in the ...

“Most Likely Not To” yet again exemplifies Genentech’s steadfast support of the SMA community ... walked the runway as part of the Double Take Fashion Show during New York Fashion Week. The event was ...

"The losers are the Genentech shareholders. Roche has just screwed anyone dumb enough to have bought over $82.50 a share," says one New York health care hedge fund manager who had no position in ...

The initial show, which is part of Genentech’s larger SMA My Way initiative, was held in September to coincide with New York Fashion Week. SMA, which is a rare disease that affects between 10,000 to ...

The first of its kind runway show took place Sept. 8 as a prelude to the start of New York Fashion Week. Genentech partnered with Open Style Lab, a nonprofit organization that creates functional ...